Drug Database
Back to search

Netherlands· NL-049463754680

Suprimal, tabletten 12,5 mg

A meclozine product containing meclozine dihydrochloride-1-water, registered in Netherlands by Remark Pharma. The same ATC class is registered in 7 of our 19 countries.

ATC R06AE05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSuprimal, tabletten 12,5 mgATCR06AE05REGISTER NO.NL-049463754680PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about meclozine dihydrochloride-1-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Meclozine is registered in 7 of 19 countries.

Countries holding a registration under ATC R06AE05 (meclozine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search meclozine products by name

Meclozine · ATC R06AE05

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MECLOZINE DIHYDROCHLORIDE-1-WATER
Manufacturer
Remark Pharma
Country
Netherlands (NL)
ATC code
R06AE05
ATC class
Meclozine
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    03189

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

283 interactions on record for meclozine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check meclozine against other medicinesHow interaction checks work

Meclozine · interactions on record

283 records

  • 9 severe
  • 269 moderate
  • 5 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • Sodium oxybateN01AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Meclozine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All meclozine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Agyrax, Postafene
  • Denmark · Postafen
  • Spain · Chiclida
  • Finland · Postafen
  • France · Agyrax, Navidoxine
  • United Kingdom (Northern Ireland) · Sea-Legs, Traveleeze
  • Greece · Emetostop
  • Iceland · Postafen
  • Luxembourg · Agyrax, Postafene
  • Norway · Postafen
  • Sweden · Postafen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/853e9f96-22c8-4312-b049-a5acd2ff3f91
GET /v1/drugs/853e9f96-22c8-4312-b049-a5acd2ff3f91?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h03189_smpc.pdf",
  "strength": null,
  "atc_label": "Meclozine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg03189",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 80 (E 433)",
    "SILICIUMDIOXIDE (E 551)",
    "ZETMEEL, GEPREGELATINEERD",
    "ZONNEGEEL FCF (E 110)"
  ],
  "substances": [
    "MECLOZINE DIHYDROCHLORIDE-1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h03189.pdf",
  "authorised_at": "1990/03/26",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "03189",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about meclozine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console